Search 

BioPartner UK is an independent, accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK life science companies.

BioPartner creates opportunities for international business partnering, operating both independently and in partnership with the UK government to support the UK Life Science sector. We work with a range of clients in the private and public sector to organise partnering events, international projects and missions. BioPartner support extends well beyond single events or missions, providing strategic consultancy, research and reports.

We are accredited by government and operate as a non-profit organisation, but our independence ensures a flexible, rapid response when assisting event managers and providing information about the UK Life Science sector.

BioPartner is associated with Meeting Mojo one-to-one partnering software, and UK BiotechNet overseas market entry and UK expertise.

Ingenza is a biotechnology company specialising in the design, development and manufacture of diverse, high-value industrial products and therapeutic-proteins. We exploit synergies between synthetic and evolutionary biology, providing next generation microbial and mammalian manufacturing platforms.

The Clinical Research Network supports research to make patients, and the NHS, better.

We are part of the National Institute for Health Research - which is the clinical research arm of the National Health Service in England.

We provide the practical support that academic and commercial life-sciences industry researchers need to make studies happen in the NHS, so that more research can take place, and more patients can take part.

This practical support includes:

• Reducing the "red-tape"​ around setting up a clinical study
• Funding the people and facilities needed to carry out research "on the ground"​, so research activity does not drain resources
• Helping researchers to identify suitable NHS sites, and recruit patients to take part in research studies
• Advising researchers on how to make their study "work"​ in the NHS environment

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway from candidate selection to commercial launch. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.

Scendea is a leading product development and regulatory consulting practice serving the pharmaceutical and biotechnology industry. We are committed problem solvers, redefining the meaning of customer service, with a focus on reducing time-to-market and minimising development costs.

                            
Scendea was founded as a result of a management buyout of the product development and regulatory consulting function of a clinical research organisation. Our origin dates back over 20 years, with involvement in over 1,000 development programmes.
Our international team offers strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory, which guide products efficiently from early development to marketing approval.

    
Our scientific excellence, industry experience, commercial awareness and a collaborative approach allow our expert team to solve complex issues associated with medicinal product development.  Scendea has team members based in the UK, Ireland, the Netherlands and the US, who deliver innovative and high-quality solutions aligned to jurisdiction-specific regulatory requirements.